𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hormone therapy and ovarian cancer: incidence and survival

✍ Scribed by Karen J. Wernli; Polly A. Newcomb; John M. Hampton; Amy Trentham-Dietz; Kathleen M. Egan

Book ID
106382641
Publisher
Springer Netherlands
Year
2008
Tongue
English
Weight
219 KB
Volume
19
Category
Article
ISSN
0957-5243

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Use of hormone replacement therapy befor
Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival
✍ Chantal Mascarenhas; Mats Lambe; Rino Bellocco; Kjell Bergfeldt; Tomas Riman; In πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 190 KB πŸ‘ 1 views

## Abstract Use of hormone replacement therapy (HRT) has been hypothesized to affect survival of epithelial ovarian cancer (EOC). We studied 5‐year survival in patients with invasive EOC and borderline ovarian tumors (BOT) according to HRT use before and after diagnosis in a prospective nation‐wide

Hormonal therapy in ovarian cancer
Hormonal therapy in ovarian cancer
✍ H. ZHENG; J.J. KAVANAGH; W. HU; Q. LIAO; S. FU πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 270 KB
Postmenopausal hormone use and incident
Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen
✍ Janet S. Hildebrand; Susan M. Gapstur; Heather Spencer Feigelson; Lauren R. Tera πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 146 KB

## Abstract Ovarian cancer has been associated in epidemiologic studies with postmenopausal hormone use. Whether associations differ by hormone regimen, current status or duration of use is unclear. We examined epithelial ovarian cancer incidence in relation to unopposed estrogen (E‐only) and estro